Harmon Cyrus sold OLMA
January 20, 2026 · Form 4 insider transaction
Harmon Cyrus sold 10,000 shares of Olema Pharmaceuticals, Inc. at $26.88 per share, a transaction worth $268.8K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
10,000
Price
$26.88
Total value
$268.8K
InsiderHarmon Cyrus
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 20, 2026
Filing dateJanuary 21, 2026
Shares owned after727,770
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
2. The weighted average sale price for the transaction reported was $26.88, and the range of prices were between $26.85 and $26.96. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.